Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

被引：666

作者：

Liu, David ^{[1
,2
]}

Schilling, Bastian ^{[3
,4
,5
]}

Liu, Derek ^{[1
,2
,6
]}

Sucker, Antje ^{[4
,5
]}

Livingstone, Elisabeth ^{[4
,5
]}

Jerby-Amon, Livnat ^{[2
]}

Zimmer, Lisa ^{[4
,5
]}

Gutzmer, Ralf ^{[7
]}

Satzger, Imke ^{[7
]}

Loquai, Carmen ^{[8
]}

Grabbe, Stephan ^{[8
]}

Vokes, Natalie ^{[1
,2
]}

Margolis, Claire A. ^{[1
,2
]}

Conway, Jake ^{[2
,6
]}

He, Meng Xiao ^{[2
,6
,9
]}

Elmarakeby, Haitham ^{[1
,2
]}

Dietlein, Felix ^{[1
,2
]}

Miao, Diana ^{[1
,2
,6
]}

Tracy, Adam ^{[2
]}

Gogas, Helen ^{[10
]}

Goldinger, Simone M. ^{[11
]}

Utikal, Jochen ^{[12
,13
]}

Blank, Christian U. ^{[14
]}

Rauschenberg, Ricarda ^{[15
,16
,17
]}

von Bubnoff, Dagmar ^{[18
]}

Krackhardt, Angela ^{[5
,19
]}

Weide, Benjamin ^{[20
]}

Haferkamp, Sebastian ^{[21
]}

Kiecker, Felix ^{[22
]}

Izar, Ben ^{[1
,2
]}

Garraway, Levi ^{[23
]}

Regev, Aviv ^{[2
]}

Flaherty, Keith ^{[24
]}

Paschen, Annette ^{[4
,5
]}

Van Allen, Eliezer M. ^{[1
,2
]}

Schadendorf, Dirk ^{[4
,5
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA

[3] Univ Hosp Wurzburg, Dept Dermatol, Wurzburg, Germany

[4] Univ Hosp, Dept Dermatol, Essen, Germany

[5] German Canc Res Ctr, German Canc Consortium Translat Canc Res, Heidelberg, Germany

[6] Harvard Med Sch, Boston, MA 02115 USA

[7] Hannover Med Sch, Dept Dermatol & Allergy, Skin Canc Ctr Hannover, Hannover, Germany

[8] Univ Med Ctr, Dept Dermatol, Mainz, Germany

[9] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA

[10] Natl & Kapodistrian Univ Athens, Dept Med 1, Athens, Greece

[11] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland

[12] Ruprecht Karl Univ Heidelberg, Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany

[13] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany

[14] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands

[15] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Fac Med, Skin Canc Ctr,Univ Canc Ctr,Dept Dermatol, Dresden, Germany

[16] Natl Ctr Tumor Dis, Dresden, Germany

[17] German Canc Res Ctr, Heidelberg, Germany

[18] Univ Freiburg, Fac Med, Med Ctr, Dept Dermatol, Freiburg, Germany

[19] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, Munich, Germany

[20] Univ Med Ctr Tubingen, Dept Dermatol, Tubingen, Germany

[21] Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany

[22] Univ Hosp Berlin, Dept Dermatol, Berlin, Germany

[23] Eli Lilly & Co, Indianapolis, IN 46285 USA

[24] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

NATURE MEDICINE | 2019年 / 25卷 / 12期

基金：

美国国家科学基金会; 美国国家卫生研究院;

关键词：

PD-1; BLOCKADE; OPEN-LABEL; CTLA-4; RESISTANCE; MUTATIONS; PEMBROLIZUMAB; IPILIMUMAB; SIGNATURES; NIVOLUMAB; MULTICENTER;

D O I：

10.1038/s41591-019-0654-5

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Immune-checkpoint blockade (ICB) has demonstrated efficacy in many tumor types, but predictors of responsiveness to anti-PD1 ICB are incompletely characterized. In this study, we analyzed a clinically annotated cohort of patients with melanoma (n = 144) treated with anti-PD1 ICB, with whole-exome and whole-transcriptome sequencing of pre-treatment tumors. We found that tumor mutational burden as a predictor of response was confounded by melanoma subtype, whereas multiple novel genomic and transcriptomic features predicted selective response, including features associated with MHC-I and MHC-II antigen presentation. Furthermore, previous anti-CTLA4 ICB exposure was associated with different predictors of response compared to tumors that were naive to ICB, suggesting selective immune effects of previous exposure to anti-CTLA4 ICB. Finally, we developed parsimonious models integrating clinical, genomic and transcriptomic features to predict intrinsic resistance to anti-PD1 ICB in individual tumors, with validation in smaller independent cohorts limited by the availability of comprehensive data. Broadly, we present a framework to discover predictive features and build models of ICB therapeutic response.

引用

页码：1916 / +

页数：26

共 77 条

[71] Genomic correlates of response to CTLA-4 blockade in metastatic melanoma [J].

Van Allen, Eliezer M. ;

Miao, Diana ;

Schilling, Bastian ;

Shukla, Sachet A. ;

Blank, Christian ;

Zimmer, Lisa ;

Sucker, Antje ;

Hillen, Uwe ;

Foppen, Marnix H. Geukes ;

Goldinger, Simone M. ;

Utikal, Jochen ;

Hassel, Jessica C. ;

Weide, Benjamin ;

Kaehler, Katharina C. ;

Loquai, Carmen ;

Mohr, Peter ;

Gutzmer, Ralf ;

Dummer, Reinhard ;

Gabriel, Stacey ;

Wu, Catherine J. ;

Schadendorf, Dirk ;

Garraway, Levi A. .

SCIENCE, 2015, 350 (6257) :207-211

[72] Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine [J].

Van Allen, Eliezer M. ;

Wagle, Nikhil ;

Stojanov, Petar ;

Perrin, Danielle L. ;

Cibulskis, Kristian ;

Marlow, Sara ;

Jane-Valbuena, Judit ;

Friedrich, Dennis C. ;

Kryukov, Gregory ;

Carter, Scott L. ;

McKenna, Aaron ;

Sivachenko, Andrey ;

Rosenberg, Mara ;

Kiezun, Adam ;

Voet, Douglas ;

Lawrence, Michael ;

Lichtenstein, Lee T. ;

Gentry, Jeff G. ;

Huang, Franklin W. ;

Fostel, Jennifer ;

Farlow, Deborah ;

Barbie, David ;

Gandhi, Leena ;

Lander, Eric S. ;

Gray, Stacy W. ;

Joffe, Steven ;

Janne, Pasi ;

Garber, Judy ;

MacConaill, Laura ;

Lindeman, Neal ;

Rollins, Barrett ;

Kantoff, Philip ;

Fisher, Sheila A. ;

Gabriel, Stacey ;

Getz, Gad ;

Garraway, Levi A. .

NATURE MEDICINE, 2014, 20 (06) :682-688

[73] Baseline tumor T cell receptor (TcR) sequencing analysis and neo antigen load is associated with benefit in melanoma patients receiving sequential nivolumab and ipilimumab [J].

Weber, J. ;

Horak, C. ;

Hodi, F. S. ;

Chang, H. ;

Woods, D. ;

Sanders, C. ;

Robins, H. ;

Yusko, E. .

ANNALS OF ONCOLOGY, 2016, 27

[74] Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial [J].

Weber, Jeffrey S. ;

Gibney, Geoff ;

Sullivan, Ryan J. ;

Sosman, Jeffrey A. ;

Slingluff, Craig L., Jr. ;

Lawrence, Donald P. ;

Logan, Theodore F. ;

Schuchter, Lynn M. ;

Nair, Suresh ;

Fecher, Leslie ;

Buchbinder, Elizabeth I. ;

Berghorn, Elmer ;

Ruisi, Mary ;

Kong, George ;

Jiang, Joel ;

Horak, Christine ;

Hodi, F. Stephen .

LANCET ONCOLOGY, 2016, 17 (07) :943-955

[75] Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab [J].

Weide, Benjamin ;

Martens, Alexander ;

Hassel, Jessica C. ;

Berking, Carola ;

Postow, Michael A. ;

Bisschop, Kees ;

Simeone, Ester ;

Mangana, Johanna ;

Schilling, Bastian ;

Di Giacomo, Anna Maria ;

Brenner, Nicole ;

Kaehler, Katharina ;

Heinzerling, Lucie ;

Gutzmer, Ralf ;

Bender, Armin ;

Gebhardt, Christoffer ;

Romano, Emanuela ;

Meier, Friedegund ;

Martus, Peter ;

Maio, Michele ;

Blank, Christian ;

Schadendorf, Dirk ;

Dummer, Reinhard ;

Ascierto, Paolo A. ;

Hospers, Geke ;

Garbe, Claus ;

Wolchok, Jedd D. .

CLINICAL CANCER RESEARCH, 2016, 22 (22) :5487-5496

[76] Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma [J].

Wolchok, J. D. ;

Chiarion-Sileni, V. ;

Gonzalez, R. ;

Rutkowski, P. ;

Grob, J. -J. ;

Cowey, C. L. ;

Lao, C. D. ;

Wagstaff, J. ;

Schadendorf, D. ;

Ferrucci, P. F. ;

Smylie, M. ;

Dummer, R. ;

Hill, A. ;

Hogg, D. ;

Haanen, J. ;

Carlino, M. S. ;

Bechter, O. ;

Maio, M. ;

Marquez-Rodas, I. ;

Guidoboni, M. ;

McArthur, G. ;

Lebbe, C. ;

Ascierto, P. A. ;

Long, G. V. ;

Cebon, J. ;

Sosman, J. ;

Postow, M. A. ;

Callahan, M. K. ;

Walker, D. ;

Rollin, L. ;

Bhore, R. ;

Hodi, F. S. ;

Larkin, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14) :1345-1356

[77] Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma [J].

Zaretsky, Jesse M. ;

Garcia-Diaz, Angel ;

Shin, Daniel S. ;

Escuin-Ordinas, Helena ;

Hugo, Willy ;

Hu-Lieskovan, Siwen ;

Torrejon, Davis Y. ;

Abril-Rodriguez, Gabriel ;

Sandoval, Salemiz ;

Barthly, Lucas ;

Saco, Justin ;

Moreno, Blanca Homet ;

Mezzadra, Riccardo ;

Chmielowski, Bartosz ;

Ruchalski, Kathleen ;

Shintaku, I. Peter ;

Sanchez, Phillip J. ;

Puig-Saus, Cristina ;

Cherry, Grace ;

Seja, N. P. Elizabeth ;

Kong, Xiangju ;

Pang, Jia ;

Berent-Maoz, Beata ;

Comin-Anduix, Begona ;

Graeber, Thomas G. ;

Tumeh, Paul C. ;

Schumacher, Ton N. M. ;

Lo, Roger S. ;

Ribas, Antoni .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (09) :819-829

← 1 2 3 4 5 6 7 8 →